FALCHI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 1.695
EU - Europa 1.122
AS - Asia 537
AF - Africa 89
OC - Oceania 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.450
Nazione #
US - Stati Uniti d'America 1.693
IT - Italia 369
GB - Regno Unito 216
CN - Cina 194
SG - Singapore 188
SE - Svezia 171
DE - Germania 105
VN - Vietnam 73
IE - Irlanda 54
IN - India 53
BG - Bulgaria 37
FR - Francia 36
TG - Togo 35
RU - Federazione Russa 27
UA - Ucraina 26
NG - Nigeria 22
EE - Estonia 21
ZA - Sudafrica 17
CH - Svizzera 12
CI - Costa d'Avorio 11
JO - Giordania 10
ES - Italia 7
BE - Belgio 6
GR - Grecia 6
HK - Hong Kong 6
NL - Olanda 6
AT - Austria 4
FI - Finlandia 4
CZ - Repubblica Ceca 3
HR - Croazia 3
ID - Indonesia 3
JP - Giappone 3
PL - Polonia 3
AU - Australia 2
BR - Brasile 2
LV - Lettonia 2
MU - Mauritius 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
BZ - Belize 1
CA - Canada 1
DK - Danimarca 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
SN - Senegal 1
TW - Taiwan 1
Totale 3.450
Città #
Fairfield 199
Southend 199
Chandler 180
Singapore 162
Ashburn 152
Bologna 143
Santa Clara 129
Woodbridge 110
Seattle 106
Houston 88
Wilmington 83
Cambridge 72
Ann Arbor 61
Dublin 54
Boardman 50
Princeton 45
Lomé 35
Dong Ket 34
Sofia 34
Redmond 26
Berlin 25
Nanjing 23
Abeokuta 20
Westminster 20
Padova 17
Milan 13
Jacksonville 12
New York 12
Saint Petersburg 12
San Diego 12
Abidjan 11
Shenyang 11
Amman 10
Nanchang 10
Genoa 9
Jinan 9
Shanghai 9
Beijing 8
Bern 7
Falls Church 7
Florence 7
Jiaxing 7
Quartu Sant'Elena 7
Bremen 6
Brussels 6
Bühl 6
Chicago 6
Council Bluffs 6
Hangzhou 6
Verona 6
Guangzhou 5
Hebei 5
Tianjin 5
Treviso 5
Turin 5
Amsterdam 4
Ferrara 4
Hong Kong 4
Kunming 4
Lucca 4
Olalla 4
Taizhou 4
Vienna 4
Changsha 3
Dearborn 3
Frankfurt am Main 3
Helsinki 3
Hyderabad 3
Jakarta 3
Lausanne 3
Mumbai 3
Mülheim 3
Norwalk 3
Ostopovice 3
Pesaro 3
Redwood City 3
Rome 3
San Cristóbal de La Laguna 3
San Giovanni in Persiceto 3
Badalona 2
Buffalo 2
Casalecchio di Reno 2
Cesenatico 2
Des Moines 2
Fremont 2
Fuzhou 2
Giussano 2
Groningen 2
Haikou 2
Harbin 2
Kiev 2
Las Vegas 2
Los Angeles 2
Medford 2
Modena 2
Mordano 2
Nanyang 2
Ningbo 2
Nuremberg 2
Pavia 2
Totale 2.429
Nome #
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 194
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 187
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 182
Protein Tunnels: The Case of Urease Accessory Proteins 155
Collecting and assessing human lactate dehydrogenase-A conformations for structure-based virtual screening 143
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 128
Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. 127
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 124
null 123
Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A 122
null 121
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity. 120
null 118
Kernel-Based, Partial Least Squares Quantitative Structure-Retention Relationship Model for UPLC Retention Time Prediction: A Useful Tool for Metabolite Identification 117
Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia 116
Targeting the Protein Tunnels of the Urease Accessory Complex: A Theoretical Investigation 115
2-Phenoxy-1,4-naphthoquinones: From a Multitarget Antitrypanosomal to a Potential Antitumor Profile 106
Protein Dynamics of the HIF-2α PAS-B Domain upon Heterodimerization and Ligand Binding 101
null 101
null 95
Searching for New Microbiome-Targeted Therapeutics through a Drug Repurposing Approach 91
null 89
Structure-based design of small-molecule protein–protein interaction modulators: the story so far 88
Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives 74
Chalcone-based carbamates for Alzheimer's disease treatment 65
Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors 64
Development of a multisite model for Ni(II) ion in solution from thermodynamic and kinetic data 61
Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity 59
Probing allosteric communication with combined molecular dynamics simulations and network analysis 39
Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5 35
Divide et impera: An in silico screening targeting hcmv ppul44 processivity factor homodimerization identifies small molecules inhibiting viral replication 34
Structure-based virtual screening allows the identification of efficient modulators of E-cadherin-mediated cell-cell adhesion 31
Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: Towards the next generation HIV-1 inhibitors 19
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3σ case 18
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors 18
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: From in silico screening to cyclodextrin formulation 18
N-(thiazol-2-yl)-2-thiophene carboxamide derivatives as Abl inhibitors identified by a pharmacophore-based database screening of commercially available compounds 17
NOVEL INHIBITORS OF PVHL-ELONGIN C BINDING 16
Fyn kinase in brain diseases and cancer: The search for inhibitors 15
COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF 15
Identification of Hck Inhibitors As Hits for the Development of Antileukemia and Anti-HIV Agents 14
Inhibitors of human immunodeficiency virus-1 replication targeting the human DEAD-box polypeptide 3 (DDX3) RNA helicase 14
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors 13
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data 12
Design and synthesis of thiadiazoles and thiazoles targeting the Bcr-Abl T315I mutant: From docking false positives to ATP-noncompetitive inhibitors 11
NON PEPTIDIC 14-3-3 INHIBITORS AND THE USE THEREOF 9
N-[2-methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a Scaffold for the synthesis of inhibitors of Bcr-Abl 9
Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3 8
Targeting the human DEAD-box polypeptide 3 (DDX3) RNA helicase as a novel strategy to inhibit viral replication 7
Next generation of antiretroviral agents targeting the RNA binding site of the HIV-1 cellular cofactor DDX3: an innovative therapeutic approach 7
Toward the Discovery of Novel Anti-HIV Drugs. Second-Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti-HIV Activity: Synthesis, Structure-Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation 6
Totale 3.571
Categoria #
all - tutte 9.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020535 0 0 0 0 0 70 103 140 102 69 26 25
2020/2021460 74 29 18 30 39 53 19 13 65 24 14 82
2021/2022548 47 5 37 17 45 29 14 90 25 35 110 94
2022/2023768 59 130 52 84 85 40 36 52 111 42 31 46
2023/2024304 11 51 15 22 16 57 9 34 9 34 29 17
2024/2025532 35 114 75 82 199 27 0 0 0 0 0 0
Totale 3.571